TELA Bio (TELA) Revenue (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.67% |
| Dec 31, 2025 | 0.87% |
| Sep 30, 2025 | 2.44% |
| Jun 30, 2025 | 9.06% |
| Mar 31, 2025 | 4.94% |
| Dec 31, 2024 | -6.90% |
| Sep 30, 2024 | 17.81% |
| Jun 30, 2024 | -3.08% |
| Mar 31, 2024 | -2.32% |
| Dec 31, 2023 | 12.93% |
| Sep 30, 2023 | 3.85% |
| Jun 30, 2023 | 21.71% |
| Mar 31, 2023 | 2.47% |
| Dec 31, 2022 | 4.15% |
| Sep 30, 2022 | 7.24% |
| Jun 30, 2022 | 26.42% |
| Mar 31, 2022 | -1.71% |
| Dec 31, 2021 | 9.41% |
| Sep 30, 2021 | 1.27% |
| Jun 30, 2021 | 28.60% |
| Mar 31, 2021 | 3.71% |
| Dec 31, 2020 | 6.66% |
| Sep 30, 2020 | 51.50% |
| Jun 30, 2020 | -5.88% |
| Mar 31, 2020 | -23.40% |
| Dec 31, 2019 | 22.43% |
| Sep 30, 2019 | 20.28% |
| Jun 30, 2019 | -0.09% |
| Mar 31, 2019 | 36.22% |
| Dec 31, 2018 | 9.72% |